Advertisement

Successful Administration of Iron Sucrose in a Patient with an Anaphylactic Reaction to Ferric Carboxymaltose

  • Sanjay VikrantEmail author
  • Ajay Jaryal
Correspondence
  • 10 Downloads

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Rognoni C, Venturini S, Meregaglia M, Marmifero M, Tarricone R (2016) Efficacy and safety of ferric carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomised controlled trials. Clin Drug Investig 36:177–194CrossRefGoogle Scholar
  2. 2.
    Venofer prescribing information. http://www.venofer.com/PDF/Venofer_IN2340_Rev_8_2015.pdf. Accessed 8 Jun 2016
  3. 3.
    Vikrant S (2007) Optimum dosage regimen for iron sucrose. Kidney Int 72:225CrossRefGoogle Scholar
  4. 4.
    Wang C, Graham DJ, Kane RC et al (2015) Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 314:2062–2068CrossRefGoogle Scholar
  5. 5.
    Haddad A, Abbadi R, Marji A (2009) Use of iron sucrose in dialysis patients sensitive to iron dextran. Saudi J Kidney Dis Transpl 20:208–211Google Scholar
  6. 6.
    Sane R, Baribeault D, Rosenberg CL (2007) Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. Pharmacotherapy 27:613–615CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  1. 1.Department of NephrologyIndira Gandhi Medical CollegeShimlaIndia

Personalised recommendations